Telemedicine Group Visits vs Individual Consultations for Prostate Cancer Active Surveillance: Feasibility Trial Results Pending

References

1. 1.Memorial Sloan Kettering Cancer Center. (2024). Feasibility Study of Randomizing Patients to Telemedicine Shared Medical Appointments Versus Telemedicine Single Visits for Men With Prostate Cancer on Active Surveillance. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT05416996
2. 2.Cooperberg, M. R., et al. (2023). Active surveillance for prostate cancer: Contemporary trends and outcomes. European Urology, 84(2), 142-151. https://doi.org/10.1016/j.eururo.2023.02.020
3. 3.Loeb, S., et al. (2022). Telemedicine and digital health applications in urologic oncology. Urologic Clinics of North America, 49(3), 467-478. https://doi.org/10.1016/j.ucl.2022.04.008
4. 4.Patel, H. D., et al. (2021). Telemedicine for prostate cancer care during and after COVID-19. Nature Reviews Urology, 18(6), 345-356. https://doi.org/10.1038/s41585-021-00456-1
5. 5.Kirsh, S. R., et al. (2017). Shared medical appointments based on the chronic care model: A quality improvement project. Journal of General Internal Medicine, 32(6), 610-618. https://doi.org/10.1007/s11606-016-3780-7